Ostatní
Návod 
Celldex Therapeutics, Inc.
CLDX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.5B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-38%
ROA
-35%
PE
-8
PS
1370
Cena 1R
14-31
⌀ Cena
23.25
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
Profil
Celldex Therapeutics, Inc., biofarmaceutická společnost, se zabývá vývojem terapeutických monoklonálních a biskupských protilátek pro léčbu různých onemocnění. Mezi jeho kandidáty patří léčiva založená na protilátkách pro léčbu pacientů se zánětlivými onemocněními a různými formami rakoviny. Program klinického vývoje společnosti CDX- 0159, monoklonální protilátka fáze I, která váže receptor tyrosinkinázy KIT a inhibuje její aktivitu; CDX- 1140, lidská agonistická monoklonální protilátka cílená na CD40, klíčový aktivátor imunitní odpovědi, která se nachází na dendritických buňkách, makrofázích a B buňkách, a je exprimována na různých nádorových buňkách; a CDX-527, biskupská protilátka, která využívá proprietické buňky společnosti k propojení kostimulace CD27 s blokádou dráhy PD-L1/PD-1, která pomáhá nastartovat a aktivovat protinádorovou odpověď T lymfocytů prostřednictvím CD27 kostimulace. Společnost spolupracuje na výzkumu a uzavírá licenční smlouvy s University of Southampton na vývoji lidských protilátek proti CD27; Amgen Inc. s výhradními právy na CDX-301 a CD40 ligand; a Yale University. Celldex Therapeutics, Inc. byla založena v roce 1983 a sídlí v Hamptonu v New Jersey.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
186
Založení
1986-05-15
Podobné společnosti
$ 28.27
+ $ 4.08
$ 3.89
- $ 0.03
$ 27.09
+ $ 0.61
$ 8.11
- $ 0.16
$ 26.00
- $ 1.80
$ 31.58
+ $ 0.15
$ 4.64
- $ 0.09
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1.5 | 1.5 | 7.0 | 6.9 | 2.4 | 4.7 | 7.4 | 3.6 | 9.5 | 12.7 | 6.8 | 5.5 | 3.6 | 4.1 | 11.2 | 9.3 | 46.8 | |
| Cost of Revenues | 0.0 | 0.0 | 163.6 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.3 | 10.8 | 9.1 | 12.1 | |
| Gross Profit | 1.5 | 1.5 | -156.5 | 3.9 | 2.4 | 4.7 | 7.4 | 3.6 | 9.5 | 12.7 | 6.8 | 5.5 | 3.6 | 1.8 | 0.4 | 0.1 | 34.7 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 0.1 | 0.0 | 0.7 | 0.7 | 1.2 | 3.2 | 2.5 | 0.2 | 4.1 | 1.5 | |
| Cost of Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.0 | 0.8 | 0.8 | 0.8 | 0.8 | |
| Gross Profit | 0.1 | 0.0 | 0.7 | 0.7 | 0.4 | 3.2 | 1.7 | -0.6 | 3.4 | 0.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 118.0 | 82.3 | 53.3 | 42.5 | 42.7 | 66.4 | 96.2 | 102.7 | 100.2 | 104.4 | 67.4 | 47.4 | 32.4 | 27.7 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 30.9 | 27.2 | 20.5 | 14.5 | 15.4 | 19.3 | 25.0 | 36.0 | 33.8 | 20.6 | 14.8 | 10.0 | 9.2 | 10.4 | |
| Depreciation & Amortization | 3.4 | 3.4 | 3.2 | 3.0 | 13.4 | 3.7 | 25.2 | -3.1 | 0.2 | 5.3 | 1.0 | 1.0 | 1.0 | 2.9 | 1.1 | 1.9 | 3.1 | |
| Total Operating Expenses | 288.9 | 288.9 | 38.5 | 161.4 | 109.5 | 73.8 | 57.0 | 58.1 | 85.9 | 122.1 | 139.7 | 135.0 | 126.0 | 83.2 | 58.5 | 43.6 | 41.2 | |
| Operating Income | -287.4 | -287.4 | -195.1 | -154.5 | -115.2 | -71.2 | -63.4 | -55.0 | -156.4 | -121.5 | -132.9 | -129.5 | -122.4 | -81.4 | -58.1 | -43.4 | -6.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 29.7 | 34.5 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.8 | 8.2 | ||
| Depreciation & Amortization | 0.8 | 0.8 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | ||
| Total Operating Expenses | 87.3 | 73.6 | 64.6 | 63.4 | 56.4 | 55.3 | 48.0 | 40.0 | 38.5 | 42.8 | ||
| Operating Income | -87.2 | -73.6 | -63.9 | -62.7 | -56.0 | -52.1 | -46.3 | -40.6 | -35.1 | -41.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 28.6 | 28.6 | 37.2 | 13.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | -2.9 | 0.0 | 0.0 | 0.0 | 151.1 | 16.0 | 0.0 | 0.0 | 0.0 | 0.9 | 1.6 | 1.8 | 1.3 | |
| Other Expense | 28.6 | 28.6 | 37.2 | 13.1 | 2.9 | 0.5 | 2.4 | 4.2 | -75.5 | -8.0 | 4.4 | 2.3 | 4.4 | 0.8 | 0.5 | 0.4 | 5.3 | |
| IBT | -258.8 | -258.8 | -157.9 | -141.4 | -112.3 | -70.7 | -60.9 | -50.9 | -151.9 | -117.3 | -128.5 | -127.2 | -118.1 | -81.6 | -59.1 | -44.8 | -2.5 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 10.5 | -0.2 | -1.2 | -0.5 | -0.8 | -24.3 | -8.8 | -2.3 | -4.4 | -0.8 | -0.5 | -0.4 | -5.3 | |
| Net Income | -258.8 | -258.8 | -157.9 | -141.4 | -122.8 | -70.5 | -59.8 | -50.4 | -151.2 | -93.0 | -128.5 | -127.2 | -118.1 | -81.6 | -59.1 | -44.8 | -2.5 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 5.8 | 6.6 | 7.3 | 8.9 | 8.9 | 10.0 | 10.5 | 7.8 | 4.3 | 3.0 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.1 | 0.0 | ||
| Other Expense | 5.8 | 6.6 | 7.3 | 8.9 | 8.9 | 10.0 | 10.5 | 7.8 | 4.3 | 3.0 | ||
| IBT | -81.4 | -67.0 | -56.6 | -53.8 | -47.1 | -42.1 | -35.8 | -32.8 | -43.3 | -38.3 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.4 | -3.0 | ||
| Net Income | -81.4 | -67.0 | -56.6 | -53.8 | -47.1 | -42.1 | -35.8 | -32.8 | -43.3 | -38.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.92 | $-2.62 | $-1.64 | $-2.02 | $-3.47 | $-14.48 | $-10.86 | $-18.99 | $-19.66 | $-19.81 | $-15.33 | $-15.37 | $-17.01 | $-1.19 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.92 | $-2.62 | $-1.64 | $-2.02 | $-3.47 | $-14.48 | $-10.86 | $-18.99 | $-19.66 | $-19.81 | $-15.33 | $-15.37 | $-17.01 | $-1.19 | |
| Shares Outstanding | 66.5 | 66.5 | 64.4 | 48.4 | 46.9 | 42.9 | 29.6 | 14.5 | 10.4 | 8.6 | 6.8 | 6.5 | 6.0 | 5.3 | 3.8 | 2.6 | 2.1 | |
| Diluted Shares Outstanding | 66.5 | 66.5 | 64.4 | 48.4 | 46.9 | 42.9 | 29.6 | 14.5 | 10.4 | 8.6 | 6.8 | 6.5 | 6.0 | 5.3 | 3.8 | 2.6 | 2.1 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.83 | $-0.81 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.83 | $-0.81 | ||
| Shares Outstanding | 66.5 | 66.4 | 66.4 | 66.4 | 66.4 | 66.3 | 66.0 | 58.9 | 52.0 | 47.3 | ||
| Diluted Shares Outstanding | 66.5 | 66.4 | 66.4 | 66.4 | 66.4 | 66.3 | 66.0 | 58.9 | 52.0 | 47.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 42.7 | 28.4 | 34.8 | 29.4 | 39.1 | 43.8 | 11.2 | 24.3 | 40.3 | 42.5 | 72.1 | 28.0 | 169.4 | 24.9 | 11.9 | 21.3 | |
| Short Term Investments | 754.8 | 696.9 | 388.8 | 275.5 | 369.1 | 150.6 | 53.2 | 69.7 | 99.1 | 147.3 | 217.8 | 173.0 | 133.6 | 59.1 | 41.4 | 39.8 | |
| Total Cash & ST Investments | 797.5 | 725.3 | 423.6 | 305.0 | 408.3 | 194.4 | 64.4 | 94.0 | 139.4 | 189.8 | 289.9 | 201.0 | 303.0 | 84.0 | 53.3 | 61.1 | |
| Accounts Receivable | 6.3 | 0.7 | 2.6 | 0.3 | 0.2 | 1.8 | 1.0 | 3.2 | 1.9 | 1.8 | 1.0 | 0.4 | 0.5 | 0.0 | 0.2 | 0.3 | |
| Inventory | 0.0 | 0.0 | 0.0 | -0.3 | -0.2 | -1.8 | -1.0 | -3.2 | 0.0 | -1.8 | -1.0 | -0.4 | 0.0 | 0.0 | 0.0 | -0.3 | |
| Other Current Assets | 8.1 | 21.2 | 5.5 | 12.7 | 2.6 | 3.4 | 2.3 | 5.1 | 3.4 | 5.8 | 5.0 | 3.9 | 1.7 | 1.2 | 1.2 | 1.8 | |
| Total Current Assets | 812.0 | 747.2 | 431.7 | 317.7 | 410.8 | 197.8 | 66.7 | 99.1 | 144.8 | 195.6 | 294.9 | 205.0 | 305.2 | 85.1 | 54.7 | 62.9 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 36.0 | 23.0 | 17.1 | 28.4 | 36.4 | 42.7 | 115.1 | 34.8 | 21.1 | 28.2 | |
| Short Term Investments | 547.2 | 607.3 | 656.2 | 696.9 | 719.6 | 759.6 | 708.8 | 386.9 | 214.2 | 224.5 | |
| Total Cash & ST Investments | 583.2 | 630.3 | 673.3 | 725.3 | 756.0 | 802.3 | 823.8 | 421.7 | 235.3 | 252.7 | |
| Accounts Receivable | 0.1 | 0.1 | 1.1 | 0.7 | 0.9 | 1.5 | 2.7 | 2.6 | 0.3 | 0.1 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Other Current Assets | 21.0 | 18.0 | 19.4 | 21.2 | 22.0 | 8.1 | 8.8 | 5.5 | 10.3 | 12.0 | |
| Total Current Assets | 604.3 | 648.4 | 693.8 | 747.2 | 778.8 | 812.0 | 835.3 | 431.7 | 245.9 | 264.8 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 6.3 | 8.2 | 6.6 | 3.7 | 3.6 | 3.8 | 4.0 | 6.1 | 10.4 | 13.2 | 11.5 | 10.5 | 10.0 | 7.2 | 9.1 | 10.8 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 91.0 | 91.0 | 9.0 | 9.0 | 9.0 | 9.0 | 9.0 | 9.0 | |
| Intangible Assets | 27.2 | 27.2 | 27.2 | 31.3 | 30.3 | 34.2 | 52.2 | 50.6 | 67.6 | 174.6 | 31.2 | 32.5 | 22.8 | 33.2 | 34.2 | 36.2 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.1 | 9.7 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.9 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Total Long-Term Assets | 33.6 | 45.2 | 33.9 | 35.0 | 33.8 | 38.0 | 56.2 | 56.7 | 170.9 | 187.8 | 42.6 | 43.0 | 41.9 | 40.4 | 43.3 | 47.0 | |
| Total Assets | 845.6 | 792.3 | 465.6 | 352.7 | 444.7 | 235.8 | 122.9 | 155.8 | 315.6 | 383.4 | 337.6 | 248.0 | 347.1 | 125.5 | 98.0 | 109.9 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 7.5 | 7.5 | 8.1 | 8.2 | 7.4 | 6.3 | 6.2 | 6.6 | 7.0 | 3.9 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.4 | |
| Intangible Assets | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 9.4 | 9.3 | 10.4 | 9.7 | 9.7 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Total Long-Term Assets | 44.1 | 44.0 | 45.7 | 45.2 | 44.3 | 33.6 | 33.5 | 33.9 | 34.3 | 34.5 | |
| Total Assets | 648.4 | 692.4 | 739.5 | 792.3 | 823.2 | 845.6 | 868.8 | 465.6 | 280.3 | 299.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.8 | 3.3 | 3.5 | 3.3 | 1.2 | 1.0 | 1.2 | 1.1 | 1.7 | 1.7 | 1.5 | 2.6 | 2.2 | 0.7 | 0.9 | 0.9 | |
| Short-Term Debt | 1.6 | 1.5 | 3.2 | 1.4 | 1.7 | 1.3 | 1.9 | 4.5 | 6.6 | 0.0 | 4.4 | 2.6 | 0.0 | 5.6 | 6.4 | 1.1 | |
| Other Current Liabilities | 22.3 | 34.8 | 24.4 | 13.8 | 1.6 | 3.4 | 2.0 | 4.5 | 6.6 | 33.5 | 4.4 | 2.6 | 18.1 | 0.4 | 7.0 | 13.2 | |
| Current Liabilities | 27.7 | 39.5 | 31.1 | 18.6 | 16.5 | 14.2 | 11.6 | 12.6 | 27.7 | 35.2 | 30.2 | 24.5 | 20.4 | 17.7 | 14.3 | 20.2 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.3 | 2.1 | 3.4 | 3.3 | 1.1 | 3.8 | 3.2 | 3.5 | 3.6 | 0.9 | |
| Short-Term Debt | 1.6 | 1.5 | 1.5 | 1.5 | 1.4 | 1.6 | 1.6 | 3.2 | 3.1 | 3.1 | |
| Other Current Liabilities | 40.6 | 29.4 | 27.1 | 34.8 | 29.6 | 22.3 | 21.4 | 24.4 | 21.2 | 11.7 | |
| Current Liabilities | 46.5 | 33.0 | 32.0 | 39.5 | 32.1 | 27.7 | 26.3 | 31.1 | 27.8 | 15.6 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.8 | 2.4 | 0.9 | 2.6 | 1.3 | 2.2 | 1.7 | 0.0 | 0.0 | 0.0 | -21.2 | 0.0 | 0.0 | 5.7 | 9.0 | 8.9 | |
| Capital Leases | 0.8 | 3.8 | 2.5 | 4.0 | 3.0 | 3.5 | 3.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 31.9 | 45.3 | 36.5 | 26.5 | 25.2 | 26.5 | 28.9 | 31.7 | 79.3 | 117.9 | 47.5 | 36.4 | 27.3 | 29.8 | 29.3 | 34.7 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1.1 | 1.5 | 1.9 | 2.4 | 1.7 | 0.8 | 0.5 | 0.9 | 1.3 | 1.7 | |
| Capital Leases | 2.6 | 3.0 | 3.4 | 3.8 | 3.1 | 0.8 | 2.1 | 0.9 | 2.8 | 3.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 50.1 | 37.0 | 36.5 | 45.3 | 37.3 | 31.9 | 30.2 | 36.5 | 33.5 | 21.8 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Retained Earnings | -1,466.0 | -1,555.2 | -1,397.4 | -1,255.9 | -1,143.6 | -1,073.1 | -1,013.3 | -962.4 | -812.5 | -719.5 | -591.0 | -463.8 | -345.7 | -264.1 | -205.0 | -160.2 | |
| Comprehensive Income | 1.8 | 3.3 | 3.3 | 1.3 | 1.9 | 2.6 | 2.6 | 2.6 | 2.6 | 2.5 | 2.3 | 2.6 | 2.7 | 2.7 | 2.7 | 2.8 | |
| Total Common Equity | 813.7 | 747.0 | 429.2 | 326.2 | 419.5 | 209.4 | 94.0 | 124.1 | 236.4 | 265.4 | 290.1 | 211.7 | 319.8 | 95.8 | 68.7 | 75.3 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Retained Earnings | -1,732.7 | -1,665.6 | -1,609.0 | -1,555.2 | -1,508.1 | -1,466.0 | -1,430.2 | -1,397.4 | -1,354.1 | -1,315.8 | |
| Comprehensive Income | 3.8 | 3.3 | 3.6 | 3.3 | 5.3 | 1.8 | 2.2 | 3.3 | 2.1 | 2.1 | |
| Total Common Equity | 598.4 | 655.4 | 703.0 | 747.0 | 785.9 | 813.7 | 838.6 | 429.2 | 246.7 | 277.5 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 2.4 | 3.8 | 2.5 | 4.0 | 3.0 | 3.5 | 3.7 | 4.5 | 6.6 | 0.0 | 4.4 | 2.6 | 0.0 | 11.3 | 15.4 | 10.0 | |
| Book Value | 813.7 | 747.0 | 429.2 | 326.2 | 419.5 | 209.4 | 94.0 | 124.1 | 236.4 | 265.4 | 290.1 | 211.7 | 319.8 | 95.8 | 68.7 | 75.3 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 598.4 | 655.4 | 703.0 | 747.0 | 785.9 | 813.7 | 838.6 | 429.2 | 246.7 | 277.5 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -150.2 | -258.8 | -157.9 | -141.4 | -112.3 | -70.5 | -59.8 | -50.9 | -151.2 | -93.0 | -128.5 | -127.2 | -118.1 | -81.6 | -59.1 | -44.8 | -2.5 | |
| Depreciation & Amortization | 3.1 | -2.5 | 3.2 | 3.0 | 2.9 | 3.1 | 3.9 | 4.9 | 3.8 | 5.3 | 4.1 | 4.0 | 3.4 | 2.9 | 3.1 | 4.2 | 5.9 | |
| Stock-Based Compensation | 29.2 | 36.2 | 34.2 | 23.9 | 15.6 | 9.0 | 3.9 | 4.6 | 8.1 | 12.3 | 15.3 | 12.8 | 6.9 | 4.5 | 2.3 | 2.3 | 2.8 | |
| Change Working Capital | 8.3 | 14.1 | -21.6 | 13.5 | -3.9 | -1.1 | -0.3 | -4.3 | -15.4 | -12.2 | -6.6 | 10.9 | 6.1 | 7.7 | 4.4 | 2.4 | -37.2 | |
| Change In Accounts Receivable | -1.4 | -1.3 | 1.9 | -2.3 | -0.2 | 1.6 | -0.8 | -0.8 | -0.8 | -0.1 | -0.8 | 0.0 | 0.1 | -0.4 | 0.1 | 0.2 | 1.3 | |
| Change In Accounts Payable | 9.3 | 11.0 | 11.6 | 9.4 | 3.1 | 3.7 | 1.6 | -13.1 | -13.1 | -8.7 | -5.0 | 0.0 | 0.0 | 7.2 | 2.1 | 2.1 | -2.5 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.9 | 1.8 | -3.6 | -0.7 | 0.0 | 0.0 | 0.6 | 2.3 | 0.2 | -0.3 | |
| Other Non-cash Items | 8.1 | 0.0 | -15.7 | -6.2 | -5.8 | -1.1 | 13.0 | -1.3 | 80.2 | 12.0 | 1.6 | 0.3 | 0.1 | 0.1 | 0.2 | 0.3 | 0.7 | |
| Cash from Operations | -121.5 | 0.0 | 0.0 | -107.3 | -103.7 | -60.9 | -40.4 | -46.4 | -75.2 | -99.9 | -113.0 | -98.9 | -101.5 | -67.7 | -49.8 | -35.7 | -30.4 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -81.3 | -67.0 | -56.6 | -53.8 | -47.1 | -42.1 | -35.8 | -32.8 | -43.3 | -38.3 | |
| Depreciation & Amortization | 3.9 | 0.8 | 0.9 | 0.9 | 0.8 | -11.6 | 0.8 | 0.8 | 0.8 | 0.8 | |
| Stock-Based Compensation | 8.9 | 8.8 | 9.2 | 9.3 | 0.0 | 9.6 | 7.6 | 7.2 | 7.2 | 7.1 | |
| Change Working Capital | 8.5 | 9.8 | 4.2 | -8.5 | 7.4 | -19.3 | 2.8 | -12.5 | 5.0 | 13.0 | |
| Change In Accounts Receivable | -1.9 | 0.0 | 1.0 | -0.4 | 0.2 | 0.7 | 1.1 | 0.0 | -2.4 | -0.1 | |
| Change In Accounts Payable | 4.6 | 13.1 | 2.1 | -8.7 | 8.0 | 6.7 | 1.7 | -4.8 | 3.9 | 8.5 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -4.0 | -1.0 | -1.7 | -2.3 | 6.4 | 8.1 | -4.7 | -3.3 | -42.1 | 38.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -32.5 | -19.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.4 | -2.7 | -1.9 | -1.8 | -1.8 | -1.2 | -1.6 | -0.7 | -0.8 | -1.8 | -2.8 | -4.9 | -1.9 | -4.2 | -0.3 | -0.5 | -2.1 | |
| Acquisitions | -12.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | 4.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -829.8 | -384.5 | -789.9 | -424.6 | -189.0 | -389.9 | -220.3 | -95.4 | -171.2 | -171.0 | -175.7 | -206.4 | -148.3 | -112.1 | -69.3 | -52.7 | -56.5 | |
| Sales of Investment | 309.8 | 596.3 | 501.7 | 320.6 | 280.7 | 174.9 | 123.6 | 113.2 | 201.5 | 219.2 | 242.8 | 161.1 | 109.2 | 38.9 | 52.4 | 51.0 | 42.4 | |
| Other Investing Activities | 12.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.3 | -1.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | |
| Cash from Investing | -521.4 | 0.0 | 0.0 | -105.8 | 89.9 | -216.2 | -98.2 | 17.1 | 29.8 | 46.5 | 68.9 | -50.2 | -41.0 | -77.4 | -17.0 | -2.2 | -16.2 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.0 | -0.4 | -0.7 | -0.3 | -0.8 | 0.6 | -0.3 | -0.3 | -0.7 | -0.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.6 | -11.8 | |
| Investments | -54.8 | -55.6 | -122.3 | -151.8 | -129.2 | -100.1 | -168.5 | -392.2 | -241.4 | -27.8 | |
| Sales of Investment | 111.5 | 116.9 | 172.8 | 195.0 | 154.0 | 148.4 | 122.1 | 77.3 | 70.9 | 39.6 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 11.8 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -171.2 | 11.6 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -11.0 | -4.0 | -12.5 | -0.2 | |
| Debt Issued | -0.9 | 3.8 | 1.3 | -1.5 | 1.0 | -0.4 | 2.8 | -0.9 | -2.0 | 6.6 | -4.4 | 1.8 | 2.6 | -0.3 | -0.1 | 17.9 | 10.2 | |
| Issuance of Common Stock | 657.5 | 0.0 | 0.0 | 216.2 | 4.1 | 269.9 | 170.8 | 16.2 | 29.0 | 51.0 | 13.9 | 188.8 | 0.0 | 295.7 | 83.8 | 36.0 | 1.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 432.2 | 0.0 | 0.0 | 0.0 | 0.0 | 2.5 | 3.4 | 0.0 | 0.4 | 0.3 | 0.5 | 4.3 | 1.2 | 4.9 | -0.1 | 4.9 | 10.0 | |
| Cash from Financing | 657.5 | 0.0 | 0.0 | 218.5 | 4.1 | 272.4 | 171.2 | 16.3 | 29.4 | 51.3 | 14.5 | 193.2 | 1.2 | 289.6 | 79.8 | 28.4 | 10.8 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 2.6 | -0.4 | -0.4 | -0.4 | 0.7 | 0.7 | 0.3 | -0.4 | -0.3 | -0.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 217.4 | 0.3 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 217.4 | 0.3 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 217.4 | 0.3 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 14.5 | 0.5 | -6.5 | 5.4 | -9.7 | -4.7 | 32.6 | -13.1 | -16.0 | -2.2 | -29.6 | 44.1 | -141.4 | 144.5 | 13.0 | -9.4 | -35.7 | |
| Closing Cash Balance | 42.7 | 28.9 | 28.4 | 34.8 | 29.4 | 39.1 | 43.8 | 11.2 | 24.3 | 40.3 | 42.5 | 72.1 | 28.0 | 169.4 | 24.9 | 11.9 | 21.3 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -7.2 | 13.0 | 5.9 | -11.2 | -8.0 | -6.3 | -72.3 | 80.3 | 13.7 | -7.1 | |
| Closing Cash Balance | 28.9 | 36.0 | 23.0 | 17.1 | 28.4 | 36.4 | 42.7 | 115.1 | 34.8 | 21.1 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -122.9 | -213.7 | -159.7 | -109.1 | -105.6 | -62.2 | -42.0 | -47.1 | -76.0 | -101.7 | -115.8 | -103.8 | -103.5 | -71.9 | -50.1 | -36.2 | -32.5 | |
| Real Free Cash Flow | -152.1 | -249.9 | -193.9 | -133.0 | -121.2 | -71.1 | -45.9 | -51.7 | -84.1 | -114.0 | -131.1 | -116.5 | -110.3 | -76.4 | -52.4 | -38.5 | -35.3 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -64.9 | -49.1 | -44.7 | -54.6 | -33.2 | -54.7 | -29.6 | -41.0 | -33.2 | -19.2 | |
| Real Free Cash Flow | -73.8 | -57.9 | -53.9 | -64.0 | -33.2 | -64.3 | -37.2 | -48.2 | -40.4 | -26.3 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -7.9 | -11.6 | -1.4 |
| P/S | 1369.9 | 245.1 | 9.4 |
| P/B | 3.4 | 3.4 | 5.2 |
| P/FCF | -8.2 | -10.6 | -1.5 |
| Market cap | $1.5 | $1.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0.4 % | 3.1 % | 0 % |
| Debt to Income | -1 % | -27.1 % | 0 % |
| Debt to Free cash flow | -1.1 % | -1808.2 % | 0 % |
| Interest expense percentage | 0 % | 8.2 % | 44.7 % |
| Current ratio | 13 | 11.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -43.3 % | -42.3 % | 0 % |
| ROA | -39.9 % | -34.1 % | 0 % |
| CapEx to Revenue | 84.2 % | 41.2 % | 0 % |
| RaD to Revenue | 0 % | 1473.6 % | 0 % |
| ROEM | 8,064.5 | 69262.5 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 68.5 % | 73 % | 68.7 % |
| Operating margin | -9855.4 % | -2133.6 % | 35.5 % |
| Net margin | -8635.8 % | -2073 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 66.4 mil | 21.4 mil |
| Employee count | 0.2 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
